YTHDF2 and neoplasm: As presented in Tsuchiya K’s research, m6A RNA methylation regulators, including YTHDF1 and YTHDF2 are associated with better patient survival and therapeutic targets related to the tumor-immune microenvironment in non-small cell lung cancer [16].